VMBIP Newsletter – July 3, 2008
Please scroll past the charts for VMBIP updates.
McKesson Performance Dashboard 
CDC Weekly Performance Metric Scorecard

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending June 13, 2008:  86.6 percent
Week Ending June 20, 2008:  82.2 percent
Week Ending June 27, 2008:  88.0 percent
Weighted Average Last 3 Weeks:    85.8 percent
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending June 13, 2008:  98.9 percent
Week Ending June 20, 2008:  99.7 percent
Week Ending June 27, 2008:  97.1 percent
Weighted Average Last 3 Weeks:   98.5 percent
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending June 13, 2008:  99.90 percent
Week Ending June 20, 2008:  99.85 percent
Week Ending June 27, 2008:  99.90 percent
Weighted Average Last 3 Weeks:  99.89 percent
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending June 13, 2008:  99.89 percent
Week Ending June 20, 2008:  99.73 percent
Week Ending June 27, 2008:  98.70 percent
Weighted Average Last 3 Weeks:  99.38 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending June 13, 2008:  99.91 percent
Week Ending June 20, 2008:  99.91 percent
Week Ending June 27, 2008:  99.93 percent
Weighted Average Last 3 Weeks:  99.92 percent
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending June 13, 2008:  100 percent
Week Ending June 20, 2008:  100 percent
Week Ending June 27, 2008:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending June 13, 2008:  100 percent
Week Ending June 20, 2008:   98 percent
Week Ending June 27, 2008: 100 percent
Weighted Average Last 3 Weeks:  99 percent  
Explanation:  
6/20: Exclusions - 5 were quarantined by sanofi and then cleared, 1 had an incorrect dock date , & 1 did not have a valid PO on arrival
6/27: 5 were excluded due to hold placed by grantee and CDC

Updated to reflect 6/20 exclusions in note below that were identified after last week’s report submission

A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		 
B.    percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder	
C1.   percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable or customer not available, or carrier damage
C2.    percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address and delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 
D.    percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	
E.    percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) and 48 (other) hrs of delivery by manufacturer
F.    percent of grantee replenishment orders McKesson faxes and e-mails receipt of to grantees within 48 hrs of delivery by manufacturer

Vaccines on Allocation DTAP-HIB, HEPB-HIB, HIB (TriHIBit, PedvaxHIB and ActHIB) and FLU;  Manufacture Shortage (Merck Hep A) Vaccines placed on backorder during the most recent week: DTAPHBIP (6660 doses) – vaccine arrived late last week and backorders have been cleared; Hep A (3485 doses) vaccine arrived late last week and backorders have been cleared; Hep AB (3415 doses) – vaccine ordered and inventory still has not arrived; Hep B-PF (1810 doses) vaccine arrived late last week and backorders have been cleared; TD (3200 doses) vaccine ordered and inventory still has not arrived 

McKesson Performance Dashboard – Shipping Metrics by Distribution Center
CDC Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending June 13, 2008:  83.7 percent
Week Ending June 20, 2008:  76.2 percent
Week Ending June 27, 2008:  84.7 percent
Weighted Average Last 3 Weeks:  81.8 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending June 13, 2008:  100 percent
Week Ending June 20, 2008:  99.6 percent
Week Ending June 27, 2008:  96.2 percent
Weighted Average Last 3 Weeks:  98.5 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending June 13, 2008:  94.5 percent
Week Ending June 20, 2008:  97.8 percent
Week Ending June 27, 2008:  98.1 percent
Weighted Average Last 3 Weeks:  96.8 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending June 13, 2008:  95.9 percent
Week Ending June 20, 2008:  99.8 percent
Week Ending June 27, 2008:  99.9 percent
Weighted Average Last 3 Weeks:  98.5 percent
Explanation:  none
 
A.   percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder – an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order
B.   percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all orders which include an allocated vaccine, and all lines of product on backorder

VMBIP Updates

•	The roll-out is complete—all grantees have transitioned to centralized vaccine distribution.  Be on the look-out for some additional grantee-targeted resources in the near future to assist you in the ongoing implementation, including an updated and expanded PPOC document, an updated PPOC contact reference guide, and an inventory of reports and other proactive notifications from CDC and McKesson to grantees.  

As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-07-03-08.rtf